Trial intelligence / Profile preview

Lienal polypeptide plus conventional therapy in progressive vitiligo

ChiCTR2500098783Phase 4Completed

Sponsor
Beijing Friendship Hospital
Start
Mar 2025
Modality
Peptides
Countries
1
01

Overview

Phase 4 trial of lienal polypeptide in Vitiligo (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Vitiligo area. Started Mar 2025; status: completed.

02

Drugs

lienal polypeptide
03

Conditions

Vitiligo

Beyond the preview

Go deeper on ChiCTR2500098783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500098783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call